Tanvex BioPharma USA, Inc. | WebDisclosure

Basculer en Français

9904	Companies
199533	Keywords
130386	Articles
106040	Press releases

Headlines Articles Press releases Tanvex BioPharma USA, Inc.

Home
Companies
Tanvex BioPharma USA, Inc.

BRIEF

published on 08/19/2024 at 13:05, 1 year 6 months ago

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
BRIEF

published on 08/19/2024 at 13:05, 1 year 6 months ago

Tanvex BioPharma USA, Inc. franchit deux étapes réglementaires aux États-Unis : la FDA approuve Nypozi(TM) et la FDA accepte la demande de licence de produits biologiques biosimilaires pour le TX-05

Traitement Du Cancer Approbation De La FDA Biosimilaire Innovation Dans Le Domaine De La Santé Neutropénie
PRESS RELEASE

published on 08/19/2024 at 13:00, 1 year 6 months ago

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05
Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing

FDA Approval Biologics Tanvex BioPharma NYPOZI TX-05
PRESS RELEASE

published on 10/16/2023 at 14:00, 2 years 4 months ago

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

Accesswire

Published on 02/20/2026 at 18:30, 18 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 3 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 18 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 40 minutes ago

Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 48 minutes ago

Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE

EQS Group

Published on 02/20/2026 at 18:36, 12 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 25 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 48 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 48 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

Les Echos

Published on 02/20/2026 at 18:00, 48 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 48 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 hour 13 minutes ago

CHIFFRE D'AFFAIRES 2025
Published on 02/20/2026 at 09:28, 9 hours 20 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 20 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE